Related Experiment Videos
Quantitation of C3 subcomponents on red cells coated with complement in vitro
Journal of Clinical Pathology
|October 1, 1980
Summary
Human red cells coated with complement were analyzed for C3 subcomponents. Classical pathway coating resulted in more C3b and C3d than alternative pathways, with reproducible antigen detection despite antiserum variability.
Area of Science:
- Immunology
- Complement System
- Red Blood Cell Analysis
Background:
- Characterizing human red blood cells coated with complement is crucial for understanding immune responses.
- Reproducibility of complement component quantification on red cells requires detailed investigation.
Purpose of the Study:
- To characterize and evaluate the reproducibility of human red blood cells coated with complement in vitro.
- To quantify the number of C3 subcomponent molecules per red blood cell using Scatchard analysis.
Main Methods:
- Scatchard analysis of equilibrium concentrations of bound and free antibody using (125)I-labelled goat anti-rabbit IgG.
- Determination of C3b and C3d molecules on red cells coated via classical and alternative complement pathways.
- Assays using different anti-C3d sera and treatments (trypsinisation, KAF) to assess antigen detection and stability.
Main Results:
- Classical pathway-coated cells had twice as much bound C3b and C3d as alternative pathway-coated cells.
- Different anti-C3d sera yielded varying antigen amounts, but results were reproducible for a given antiserum and cell type.
- Trypsinisation and KAF treatment significantly reduced C3b on classical pathway-coated cells, with trypsinisation also reducing C3b on alternative pathway-coated cells.
Conclusions:
- The study provides a reproducible method for quantifying complement components on red blood cells.
- Differences in C3 subcomponent deposition and detection highlight the distinct roles of classical and alternative complement pathways.
- The minimal detectable levels of C3d and C3b by agglutination were established, offering insights into diagnostic assay sensitivity.